Seamless and early gap healing of osteochondral defects by autologous mosaicplasty combined with bioactive supramolecular nanofiber-enabled gelatin methacryloyl (BSN-GelMA) hydrogel
Hongwei Wu,Yuna Shang,Wei Sun,Xinyi Ouyang,Wenyan Zhou,Jieji Lu,Shuhui Yang,Wei Wei,Xudong Yao,Xiaozhao Wang,Xianzhu Zhang,Yishan Chen,Qiulin He,Zhimou Yang,Hongwei Ouyang
DOI: https://doi.org/10.1016/j.bioactmat.2022.03.038
IF: 18.9
2023-01-01
Bioactive Materials
Abstract:Highlights•A novel strategy that can effectively enhance post-mosaicplasty interstitial integration was developed.•The bioactive supramolecular nanofibers (BSN) exhibited comparable bioactivity to insulin-like growth factor-1 (IGF-1).•The BSN-GelMA hydrogel is a promising off-the-shelf bioactive material for cell-free in situ tissue regeneration.Autologous mosaicplasty is a common approach used to treat osteochondral defects in clinical practice. Gap integration between host and transplanted plugs requires bone tissue reservation and hyaline cartilage regeneration without uneven surface, graft necrosis and sclerosis. However, poor gap integration is a serious concern, which eventually leads to deterioration of joint function. To deal with such complications, this study has developed a strategy to effectively enhance integration of the gap region following mosaicplasty by applying injectable bioactive supramolecular nanofiber-enabled gelatin methacryloyl (GelMA) hydrogel (BSN-GelMA). A rabbit osteochondral defect model demonstrated that BSN-GelMA achieved seamless osteochondral healing in the gap region between plugs of osteochondral defects following mosaicplasty, as early as six weeks. Moreover, the International Cartilage Repair Society score, histology score, glycosaminoglycan content, subchondral bone volume, and collagen II expression were observed to be the highest in the gap region of BSN-GelMA treated group. This improved outcome was due to bio-interactive materials, which acted as tissue fillers to bridge the gap, prevent cartilage degeneration, and promote graft survival and migration of bone marrow mesenchymal stem cells by releasing bioactive supramolecular nanofibers from the GelMA hydrogel. This study provides a powerful and applicable approach to improve gap integration after autologous mosaicplasty. It is also a promising off-the-shelf bioactive material for cell-free in situ tissue regeneration.Graphical abstractOverall schematic of the study: IGF-1bioactive supramolecular nanofiber (IGF-1bsn) functions as an activator for promoting cell proliferation, migration and inhibiting apoptosis of the graft and promote the osteochondral gap integration eventually. (A) Osteochondral defect in the distal femoral trochlear. (B) The osteochondral defect received regular autologous mosaicplasty. (C) Common complications from the regular autologous mosaicplasty: osteosclerosis, necrosis and fibrosis. (D and E) Osteochondral defect received autologous mosaicplasty together with GelMA hydrogel containing IGF-1bsn. (F) The IGF-1bsn enhance seamless and early healing of bone graft via promoting BMSCs' migration and graft viability. (G) IGF-1bsn influences cell behavior via activating the IGF-1 receptor pathway.Download : Download high-res image (316KB)Download : Download full-size image
engineering, biomedical,materials science, biomaterials